Tesamorelin 60mg — Vial Spec, Reconstitution Math & COA

Overview of the Tesamorelin 60mg Research Specification

In high-throughput laboratory settings, single-vial research compounds with larger unit masses allow investigators to maintain continuous assays without frequent lot transitions. A 60mg vial of tesamorelin 60mg contains a concentrated, lyophilized cake of the synthetic growth hormone-releasing hormone (GHRH) analog. This high-capacity spec is typically requested by institutional research groups conducting extended animal models or automated cell-culture experiments requiring high-dose baseline standardizations.

While PX1 Research provides high-volume, enterprise-scale manufacturing runs upon request, our standardized single-unit catalog stocks the tesamorelin 10mg vial for general analytical use. Researchers needing specialized 60mg unit configurations or custom high-mass fills can review our complete catalog at /all-peptides or consult our institutional accounts team for bulk batch scheduling. Regardless of vial yield, all synthesized lots undergo identical analytical verification standards to guarantee chemical identity and sequence purity.

Chemical Structure and Preclinical Mechanism of Action

Tesamorelin is a 44-amino-acid polypeptide stabilized by a trans-3-hexenoic acid group attached to its N-terminus. This structural modification enhances enzymatic stability against dipeptidyl peptidase-IV (DPP-IV) cleavage relative to endogenous GHRH (1-44). As a selective GHRH analog, the compound binds directly to the growth hormone-releasing hormone receptor (GHRHR) on pituitary somatotropes in vitro and in animal models, triggering signal transduction pathways that elevate endogenous growth hormone (GH) secretion.

Preclinical studies suggest that the downstream elevation of insulin-like growth factor 1 (IGF-1) initiated by GHRH receptor stimulation plays an integral role in regulating lipid metabolism, cellular proliferation, and tissue repair pathways. In vitro data indicate that high-affinity binding to pituitary receptors promotes pulsatile GH discharge without disrupting feedback inhibition loops mediated by somatostatin. Research models evaluating visceral adiposity, hepatic lipid accumulation, and cellular regeneration utilize these biochemical mechanisms to quantify metabolic gene expression and protein turnover.

Reconstitution Mathematics for 60mg Lyophilized Mass

Reconstituting a 60mg lyophilized cake requires accurate volumetric calculations to achieve target concentration thresholds for laboratory instrumentation. Because a 60mg cake represents a substantial physical peptide volume, researchers must factor displacement into final concentration metrics when adding sterile bacteriostatic water or standard physiological diluents.

To streamline calculations across varying solvent volumes, researchers can utilize the following reference concentrations for a 60mg vial:

• 2.0 mL Diluent Addition: Yields a concentration of 30.0 mg/mL (30.0 µg/µL). • 3.0 mL Diluent Addition: Yields a concentration of 20.0 mg/mL (20.0 µg/µL). • 5.0 mL Diluent Addition: Yields a concentration of 12.0 mg/mL (12.0 µg/µL). • 6.0 mL Diluent Addition: Yields a concentration of 10.0 mg/mL (10.0 µg/µL).

Adding 1.0 mL or less directly to a 60mg lyophilized cake is generally discouraged due to concentration saturation limits and difficulty achieving total dissolution without aggressive vortexing, which can shear peptide chains. To verify specific working volumes, micro-liter adjustments, and syringe scale alignments, researchers should utilize our interactive reconstitution calculator before diluent addition.

Aliquot Planning and Assay Micro-Dispensing

Because reconstituted peptides degrade rapidly in liquid phase at standard room temperatures, reconstituting a 60mg vial requires an organized aliquot plan. Repeated freeze-thaw cycles alter the physical conformation of the peptide, inducing aggregation and reducing binding affinity during receptor assays. Once fully dissolved, the primary stock solution should immediately be divided into single-use micro-centrifuge tubes.

For example, if a study design requires 1.0 mg working samples per assay day, a 60mg vial reconstituted with 6.0 mL of diluent (10 mg/mL concentration) can be micro-dispensed into sixty 100 µL aliquots using calibrated pipettes. These individual sub-vials should be flash-frozen at -20°C or -80°C until needed. This protocol preserves batch-wide chemical integrity, prevents physical degradation, and eliminates the loss of structural activity associated with multi-use solution containers.

Solubility, pH Buffer Parameters, and Storage Protocols

In its lyophilized state, Tesamorelin exhibits superior chemical stability when stored away from direct light exposure at -20°C. Upon receipt, lyophilized vials should remain sealed inside desiccated packaging until laboratory preparation. The physical cake structure should appear uniform, white to off-white, without collapse or moisture intrusion.

Reconstitution should be conducted using sterile reconstituted diluents such as bacteriostatic water containing 0.9% benzyl alcohol, or standard phosphate-buffered saline (PBS) adjusted to a neutral pH range (6.8–7.4). Solvents with extreme pH values must be avoided to prevent deamidation or peptide cleavage. Once reconstituted, liquid solutions are stable at 2°C to 8°C for short-term evaluation (up to 14 days) or at -80°C for extended storage up to six months.

Analytical Quality Control and Lot-Matched COA Verification

High-capacity peptide fills require absolute quality assurance to prevent batch-wide research variations. PX1 Research enforces strict analytical standards across every production run. Each lot is subjected to high-performance liquid chromatography (HPLC) to verify molecular purity, alongside mass spectrometry (MS) to confirm exact molecular weight (5135.9 Da for Tesamorelin free base).

Additionally, bacterial endotoxin testing via Limulus Amebocyte Lysate (LAL) assays ensures that total endotoxin content remains below <0.01 EU/mg, preventing inflammatory interference in cell-culture or animal research models. Investigators can access, download, and review authentic lot-matched certificates of analysis directly at /coa. Every document outlines exact HPLC retention times, mass spectral peaks, purity percentages (guaranteed ≥99%), and lab technician sign-offs.

Comparative Analysis: GHRH Analogs and Secretagogues in Research

When designing protocols investigating the growth hormone axis, researchers often evaluate several distinct classes of peptides. Tesamorelin is recognized for its potent, targeted activation of pituitary GHRH receptors without causing rapid receptor desensitization. Understanding how it compares to alternative research compounds is essential for selecting appropriate experimental controls.

For instance, cjc-1295-no-dac is a modified 29-amino-acid GHRH fragment that offers short half-life kinetics suitable for studying acute GH pulses. In contrast, sermorelin represents the truncated 1-29 sequence of endogenous GHRH, providing a baseline control for basic receptor binding studies. Meanwhile, compounds like ipamorelin act on an entirely different receptor system—the ghrelin/growth hormone secretagogue receptor (GHS-R1a)—rather than the GHRH receptor. Combining or comparing these distinct signaling pathways allows researchers to delineate pituitary signaling pathways in complex endocrine research.

Selecting Mass Specs: 60mg vs. Standard 10mg Configurations

Choosing between a 60mg high-capacity vial and smaller standard configurations such as tesamorelin 10mg depends primarily on experimental scale, total sample sizes, and reconstitution logistics. While 10mg vials are ideal for short-duration studies or low-volume in vitro assays, high-density 60mg formats offer practical advantages for large-scale projects.

Key considerations for vial size selection include:

• Extended Animal Cohorts: Larger mass specs reduce vial-to-vial variability across multi-subject rodent groups. • Automated Dispensing Systems: High-volume stock solutions integrate seamlessly into automated liquid handling platforms. • Storage Efficiency: Managing fewer total physical vials reduces freezer footprint and simplifies inventory tracking. • Bulk Laboratory Sourcing: High-volume laboratories managing continuous research models can request customized supply scheduling through our wholesale hub.

Preclinical Research Applications: Adiposity, Metabolism, and Repair

Preclinical research utilizing GHRH analogs focuses heavily on metabolic regulation, visceral adipose tissue dynamics, and cellular repair processes. In animal models of metabolic dysfunction, Tesamorelin administration has been shown to downregulate lipogenic gene expression, leading to reductions in trunk fat and hepatic triglyceride storage without altering systemic glucose homeostasis.

Furthermore, in vitro data indicate that upregulation of the downstream GH/IGF-1 axis stimulates satellite cell activation, collagen synthesis, and protein deposition in damaged musculoskeletal tissue models. Researchers studying cardiac tissue remodeling, peripheral neuropathy, and arterial stiffness also employ Tesamorelin to investigate the systemic protective effects of regulated IGF-1 elevation.

PX1 Research Supply Chain and Laboratory Standards

All research compounds distributed by PX1 Research are synthesized in USA-based, ISO 17025 accredited and GMP-compliant manufacturing facilities. We enforce tight quality boundaries to guarantee that research facilities receive stable, highly pure chemical isolates suitable for publishable academic and clinical trial support.

Orders are dispatched directly from our dual logistics facilities in California and Arizona, providing rapid transit and thermal-controlled packaging options to preserve compound stability during transit. To explore our complete inventory of metabolic compounds, strength cluster peptides, and endocrine signaling research tools, visit our central research portal.